Gefitinib Genthon

Gefitinib Genthon is an oral medication used for targeted therapy in certain cancer treatments. This pharmaceutical is designed to inhibit specific proteins that contribute to cancer cell growth.

Gefitinib Genthon is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its role in targeted cancer therapy.

Common effects of Gefitinib Genthon may include skin rash, diarrhea, and fatigue. Some users might experience appetite loss or nausea. These effects can vary widely among individuals and are not exhaustive.

Gefitinib Genthon should be handled with care, especially by those with pre-existing liver or kidney conditions. It is important to follow the advice of a healthcare professional regarding its use and to monitor for any adverse reactions.

Gefitinib Genthon may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to consult a healthcare provider before combining it with other treatments, especially those known to affect liver function.